Idox plc
(‘Idox’ or the ‘Group’ or the ‘Company’)
Exercise of Share Options &
Total Voting Rights
Idox plc (AIM: IDOX) a leading supplier of specialist information management solutions and services, announces that it has issued 50,000 new Ordinary shares of 1 pence each in the Company (“Ordinary Shares“) pursuant to an exercise of options by one employee under its Idox Plc Share Option Plan.
Applications have been made for the 50,000 new Ordinary Shares to be admitted to trading on AIM (“Admission”). It is expected that Admission will occur at 8.00 a.m. on or around 16 October 2020.
The total number of Ordinary Shares in issue following Admission will be 444,969,622. The Company holds 1,541,219 Ordinary Shares in treasury. Therefore the total number of Ordinary Shares with voting rights in the Company will be 443,478,403.
The above figure of 443,478,403 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure and Transparency Rules.
-Ends-
Enquiries:
| Idox plc | +44 (0) 870 333 7101 | |
| Chris Stone, Non-Executive Chairman | ||
| David Meaden, Chief Executive | ||
| Rob Grubb, Chief Financial Officer | ||
| Peel Hunt LLP (NOMAD and Broker) | +44 (0) 20 7418 8900 | |
| Edward Knight | ||
| Nick Prowting | ||
| James Steel | ||
| MHP Communications | + 44 (0) 203 128 8100 | |
| Reg Hoare | [email protected] | |
| James Bavister | ||
| Amy O’Sullivan | ||
About Idox plc
For more information see www.idoxplc.com @Idoxgroup
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
Rule 26
Information last updated: 13 October 2020